Wellington Management Group’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324M Sell
3,889,687
-523,246
-12% -$41.4M 0.06% 273
2025
Q4
$343M Sell
4,412,933
-782,758
-15% -$52.9M 0.06% 272
2025
Q3
$294M Sell
5,195,691
-176,370
-3% -$7.95M 0.05% 303
2025
Q2
$234M Sell
5,372,061
-624,812
-10% -$21.5M 0.04% 323
2025
Q1
$164M Buy
5,996,873
+689,547
+13% +$25.1M 0.03% 398
2024
Q4
$214M Buy
5,307,326
+688,967
+15% +$31.1M 0.04% 354
2024
Q3
$219M Buy
4,618,359
+308,954
+7% +$13.6M 0.04% 372
2024
Q2
$129M Buy
4,309,405
+15,708
+0.4% +$544K 0.02% 480
2024
Q1
$173M Sell
4,293,697
-521,861
-11% -$18.7M 0.03% 417
2023
Q4
$123M Sell
4,815,558
-7,771
-0.2% -$139K 0.02% 519
2023
Q3
$67M Buy
4,823,329
+646
+0% +$13K 0.01% 628
2023
Q2
$111M Buy
4,822,683
+531,665
+12% +$15.2M 0.02% 524
2023
Q1
$127M Sell
4,291,018
-300,071
-7% -$9.68M 0.03% 487
2022
Q4
$115M Buy
4,591,089
+1,180,703
+35% +$31.5M 0.02% 497
2022
Q3
$74.2M Sell
3,410,386
-1,624,554
-32% -$42.8M 0.02% 584
2022
Q2
$99.1M Buy
5,034,940
+1,809,191
+56% +$42.3M 0.02% 540
2022
Q1
$137M Buy
3,225,749
+530,935
+20% +$22.4M 0.02% 518
2021
Q4
$171M Buy
2,694,814
+226,879
+9% +$13.2M 0.03% 487
2021
Q3
$145M Buy
2,467,935
+1,639,994
+198% +$95.1M 0.02% 518
2021
Q2
$40.2M Buy
827,941
+158,648
+24% +$6.89M 0.01% 895
2021
Q1
$26M Sell
669,293
-1,021,286
-60% -$61.5M ﹤0.01% 1004
2020
Q4
$104M Sell
1,690,579
-73,605
-4% -$3.59M 0.02% 580
2020
Q3
$55.8M Buy
+1,764,184
New +$53.9M 0.01% 669

Other funds holding KYMR